Today

Trump Threatens 50% Tariffs on Brazil

A.M. Edition for July 10. President Trump justifies a new tariff threat on Brazilian goods by citing the country’s ‘witch-hunt’ against former Brazilian president Jair Bolsonaro and legal action taken against U.S. tech firms. WSJ reporter Gavin Bade breaks down the economic and l ... Show More

12m 37s

Yesterday

What Linda Yaccarino’s Departure Means for X

P.M. Edition for July 9. After about two years at the helm of Elon Musk’s social-media platform, Linda Yaccarino has stepped down as the CEO of X. WSJ advertising editor Suzanne Vranica discusses what that means for X, which recently merged with Musk’s artificial intelligence com ... Show More

13m 6s

Yesterday

Trump Calls Out Putin Over Ukraine

A.M. Edition for July 9. As Russia intensifies its assault on Ukraine, President Trump is losing his patience with Vladimir Putin. Journal correspondent Matthew Luxmoore says the president is now considering sending an additional patriot missile system to Kyiv. Plus, the Trump ad ... Show More

15m 11s

Apr 26

What’s News in Markets: Capital One Gains, Consumer Conglomerate Woes, Alphabet Earnings Shine

Why did Capital One’s merger news please investors? And how are tariffs worrying consumer conglomerates like Procter & Gamble? Plus, how Google parent Alphabet’s financials are holding up–for now. Host Francesca Fontana discusses the biggest stock moves of the week and the news t ... Show More

5m 33s

May 21

Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

Blockbuster drugs. Rising profits. Strong sales. And yet, Novo Nordisk, the Danish company behind the GLP-1 drugs Ozempic and Wegovy, made a surprising move last week: It pushed out its CEO. WSJ's Peter Loftus charts the rise of Ozempic and the fall of CEO Lars Jorgensen. Jessica ... Show More

20m 12s

Jul 2024

Dow Falls More Than 500 Points

Plus: Shares of Eli Lilly and Novo Nordisk decline as competition in the anti-obesity drug market ramps up. After the bell, Netflix reported stronger revenue, but said subscriber growth in the current quarter will be weaker than a year ago. J.R. Whalen reports. Sign up for the WS ... Show More

2m 37s

Jun 21

What’s News in Markets: U.S. Steel Deal, SunRun Sinks, 23andMe Slides

How did U.S. Steel shares react to White House deal approval? And why did solar stocks slide after Senate revisions to the big budget bill? Plus, what’s the latest twist in the 23andMe sale drama? Host Francesca Fontana discusses the biggest stock moves of the week and the news t ... Show More

5m 21s

Aug 2024

What’s News in Markets: Meta’s Ads, Moderna’s Health, Intel’s Struggles

How is Meta’s advertising business doing? And is Moderna in trouble after the end of the pandemic? Plus, why did Intel’s stock short-circuit? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Learn more about your ad choices. Visit ... Show More

5m 16s

Jan 2025

U.S. Indexes Trim Gains After Strong Week

Plus: American Express shares fell after its outlook for the year disappointed investors. Verizon stock rose after beating Wall Street expectations. And Novo Nordisk surged after positive results from a clinical trial of an experimental weight loss drug. Danny Lewis reports. Sign ... Show More

2m 32s

Oct 2024

U.S. Stocks End the Week Higher

Plus: Netflix shares hit a record high following its most profitable quarter ever. And CVS Health fell after the healthcare giant replaced its CEO and warned on earnings. Plus, french fry producer Lamb Weston’s shares soar. Danny Lewis hosts. Sign up for the WSJ's free What's New ... Show More

2m 45s

What’s News in Markets: Lilly Surges, Un...